Adams Clinical Announces Appointment of Dr. Colin Sauder as Chief Scientific Officer and Expansion of Clinical Team to Support Strategic Growth
Adams Clinical Site Network (“Adams”, or the “Company”), a leading Neuroscience-focused clinical trial site network announced today that Dr. Colin Sauder, PhD has joined the company as Chief Scientific Officer. In his role, Dr. Sauder will oversee clinical and operational teams critical to the company’s strategic growth, including Principal Investigators and Clinical Operations across all Adams Clinical site locations.
